OSLO, Norway, April 01 2020 – LINK Medical Research, the Northern European clinical research organization (CRO), has today announced the opening of its new UK office at MedCity, in London’s City region. The UK is a global leader in science and innovation, and one of the busiest markets for clinical research in Europe. The expansion to London will enable LINK Medical to bring significant value to UK-based biopharma and medtech companies by accelerating their product development.
LINK Medical is a full-service CRO providing product development services for the pharmaceutical and medical device industries across Northern Europe. The service offering includes a specialized oncology team with broad multidisciplinary knowledge and long experience in overcoming challenges at every step of the development journey. The company’s Scandinavian roots and culture ensure provision of high-quality service delivery based on respect, work integrity and a strong focus on solutions. The MedCity location was strategically chosen for its world-leading life sciences cluster that supports life sciences investment, entrepreneurship, and expertise.
LINK Medical CEO, Dr. Ola Gudmundsen says “We look forward to start building on the competent team already present in the UK to further engage with this important market. We can now offer our customers enhanced service capacity in the UK, helping to drive forward their clinical projects, and thus supporting and improving healthcare for all.”
LINK Medical takes a pragmatic approach to problem-solving. The company’s experienced teams are dedicated to improving and accelerating product development through transformative methods, active communication, and optimal solutions.
For further information on LINK Medical Research: https://linkmedical.eu/
About LINK Medical
LINK Medical is a full-service contract research organization (CRO) providing product development services for the pharmaceutical and medical device industries across Northern Europe. We offer a well-integrated local presence in the Nordics, Germany, and UK. Reaching from early phase development to post-marketing, we have over 170 employees providing expert guidance across every aspect of a project – all from ONE source. Our promise is to improve and accelerate your product development through transformative methods, active communication, and optimal solutions. As a strategic partner, we provide expert competence and technology to enable evidence-based decision-making that supports the delivery of superior clinical outcomes.
EVP International Operations, email@example.com
MedCity Ltd, Cocoon Global 科控全球| 4 Christopher St, London, EC2A 2BS